Predicting survival after Impella implantation in patients with cardiogenic shock: The J-PVAD risk score.
Cardiogenic shock
Impella
Mechanical circulatory support
Percutaneous ventricular assist device
Prediction
Risk score
Journal
European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595
Informations de publication
Date de publication:
19 Sep 2024
19 Sep 2024
Historique:
revised:
02
09
2024
received:
08
07
2024
accepted:
04
09
2024
medline:
20
9
2024
pubmed:
20
9
2024
entrez:
20
9
2024
Statut:
aheadofprint
Résumé
Impella has become a new option for mechanical circulatory support in patients with cardiogenic shock (CS); however, prognostic models for patients after Impella are lacking. We aimed to identify the factors that predict in-hospital mortality in patients with CS requiring Impella and develop a new risk prediction model. We utilized the J-PVAD registry, which includes all cases where Impella was implanted in Japan. Two-thirds of the patients in the J-PVAD registry were randomly assigned to the derivation cohort (n = 1701), and the other third was assigned to the validation cohort (n = 850). A backward stepwise logistic regression model was developed to identify factors associated with in-hospital mortality. In the derivation cohort, 956 patients were discharged alive, and 745 patients (43.8%) died during hospitalization. Among 29 candidate variables, 12 were independently associated with in-hospital mortality and were applied as components of the risk model, including age, sex, body mass index, fulminant myocarditis aetiology, cardiac arrest in hospital, baseline veno-arterial extracorporeal membrane oxygenation use, mean arterial pressure, lactate, lactate dehydrogenase, total bilirubin, creatinine, and albumin levels. The comparison of predicted and observed in-hospital mortality according to the 7th quantiles using the J-PVAD risk score showed good calibration. The area under the curve for the J-PVAD risk score was 0.76 (95% confidence interval 0.73-0.78). In the validation cohort, the J-PVAD risk score showed good calibration and discrimination ability. The J-PVAD risk score can be calculated using variables easily obtained in routine clinical practice. It helps the accurate stratification of mortality risk and facilitates clinical decision-making.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Chioncel O, Parissis J, Mebazaa A, Thiele H, Desch S, Bauersachs J, et al. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:1315–1341. https://doi.org/10.1002/ejhf.1922
Reyentovich A, Barghash MH, Hochman JS. Management of refractory cardiogenic shock. Nat Rev Cardiol 2016;13:481–492. https://doi.org/10.1038/nrcardio.2016.96
van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al.; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; Mission: Lifeline. Contemporary management of cardiogenic shock: A scientific statement from the American Heart Association. Circulation 2017;136:e232–e268. https://doi.org/10.1161/CIR.0000000000000525
Kondo T, Araki T, Imaizumi T, Sumita Y, Nakai M, Tanaka A, et al. Prognosis in patients with cardiogenic shock who received temporary mechanical circulatory support. JACC Asia 2023;3:122–134. https://doi.org/10.1016/j.jacasi.2022.10.004
Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M, et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non‐infarction related cardiogenic shock in the United States. Clin Res Cardiol 2018;107:287–303. https://doi.org/10.1007/s00392‐017‐1182‐2
Lang CN, Kaier K, Zotzmann V, Stachon P, Pottgiesser T, von Zur Muehlen C, et al. Cardiogenic shock: Incidence, survival and mechanical circulatory support usage 2007‐2017 – insights from a national registry. Clin Res Cardiol 2021;110:1421–1430. https://doi.org/10.1007/s00392‐020‐01781‐z
Schrage B, Becher PM, Gossling A, Savarese G, Dabboura S, Yan I, et al. Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock. ESC Heart Fail 2021;8:1295–1303. https://doi.org/10.1002/ehf2.13202
Danial P, Olivier ME, Bréchot N, Ponnaiah M, Schoell T, D'Alessandro C, et al. Association between shock etiology and 5‐year outcomes after venoarterial extracorporeal membrane oxygenation. J Am Coll Cardiol 2023;81:897–909. https://doi.org/10.1016/j.jacc.2022.12.018
Peigh G, Cavarocchi N, Keith SW, Hirose H. Simple new risk score model for adult cardiac extracorporeal membrane oxygenation: Simple cardiac ECMO score. J Surg Res 2015;198:273–279. https://doi.org/10.1016/j.jss.2015.04.044
Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, et al. Predicting survival after ECMO for refractory cardiogenic shock: The survival after veno‐arterial‐ECMO (SAVE)‐score. Eur Heart J 2015;36:2246–2256. https://doi.org/10.1093/eurheartj/ehv194
Harjola VP, Lassus J, Sionis A, Kober L, Tarvasmaki T, Spinar J, et al. Clinical picture and risk prediction of short‐term mortality in cardiogenic shock. Eur J Heart Fail 2015;17:501–509. https://doi.org/10.1002/ejhf.260
Muller G, Flecher E, Lebreton G, Luyt CE, Trouillet JL, Bréchot N, et al. The ENCOURAGE mortality risk score and analysis of long‐term outcomes after VA‐ECMO for acute myocardial infarction with cardiogenic shock. Intensive Care Med 2016;42:370–378. https://doi.org/10.1007/s00134‐016‐4223‐9
Pöss J, Köster J, Fuernau G, Eitel I, de Waha S, Ouarrak T, et al. Risk stratification for patients in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2017;69:1913–1920. https://doi.org/10.1016/j.jacc.2017.02.027
Wengenmayer T, Duerschmied D, Graf E, Chiabudini M, Benk C, Mühlschlegel S, et al. Development and validation of a prognostic model for survival in patients treated with venoarterial extracorporeal membrane oxygenation: The PREDICT VA‐ECMO score. Eur Heart J Acute Cardiovasc Care 2019;8:350–359. https://doi.org/10.1177/2048872618789052
Bernhardt AM, Copeland H, Deswal A, Gluck J, Givertz MM, Bernhardt AM, et al. The International Society for Heart and Lung Transplantation/Heart Failure Society of America guideline on acute mechanical circulatory support. J Heart Lung Transplant 2023;42:e1–e64. https://doi.org/10.1016/j.healun.2022.10.028
Lorusso R, Shekar K, MacLaren G, Schmidt M, Pellegrino V, Meyns B, et al. ELSO interim guidelines for venoarterial extracorporeal membrane oxygenation in adult cardiac patients. ASAIO J 2021;67:827–844. https://doi.org/10.1097/MAT.0000000000001510
Pappalardo F, Schulte C, Pieri M, Schrage B, Contri R, Soeffker G, et al. Concomitant implantation of Impella(R) on top of veno‐arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail 2017;19:404–412. https://doi.org/10.1002/ejhf.668
Schrage B, Becher PM, Bernhardt A, Bezerra H, Blankenberg S, Brunner S, et al. Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: Results from an international, multicenter cohort study. Circulation 2020;142:2095–2106. https://doi.org/10.1161/CIRCULATIONAHA.120.048792
Møller JE, Engstrøm T, Jensen LO, Eiskjær H, Mangner N, Polzin A, et al.; DanGer Shock Investigators. Microaxial flow pump or standard care in infarct‐related cardiogenic shock. N Engl J Med 2024;390:1382–1393. https://doi.org/10.1056/NEJMoa2312572
Tindale A, Vela MM, Panoulas V. Using base excess, albumin, lactate, and renal function to predict 30‐day mortality in patients requiring Impella monotherapy for left‐sided mechanical circulatory support: The BALLAR score. Cardiovasc Revasc Med 2022;41:129–135. https://doi.org/10.1016/j.carrev.2021.12.008
Sreenivasan J, Khan MS, Sharedalal P, Hooda U, Fudim M, Demmer RT, et al. Obesity and outcomes following cardiogenic shock requiring acute mechanical circulatory support. Circ Heart Fail 2021;14:e007937. https://doi.org/10.1161/CIRCHEARTFAILURE.120.007937
Kwon W, Lee SH, Yang JH, Choi KH, Park TK, Lee JM, et al. Impact of the obesity paradox between sexes on in‐hospital mortality in cardiogenic shock: A retrospective cohort study. J Am Heart Assoc 2022;11:e024143. https://doi.org/10.1161/JAHA.121.024143
Tao WX, Qian GY, Li HD, Su F, Wang Z. Body mass index and outcomes of patients with cardiogenic shock: A systematic review and meta‐analysis. World J Clin Cases 2022;10:10956–10966. https://doi.org/10.12998/wjcc.v10.i30.10956
Schäfer A, Werner N, Burkhoff D, Sieweke JT, Zietzer A, Masyuk M, et al. Influence of timing and predicted risk on mortality in Impella‐treated infarct‐related cardiogenic shock patients. Front Cardiovasc Med 2020;7:74. https://doi.org/10.3389/fcvm.2020.00074
Chatzis G, Markus B, Syntila S, Waechter C, Luesebrink U, Ahrens H, et al. Comparison of mortality risk models in patients with postcardiac arrest cardiogenic shock and percutaneous mechanical circulatory support. J Interv Cardiol 2021;2021:8843935. https://doi.org/10.1155/2021/8843935
Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991;100:1619–1636. https://doi.org/10.1378/chest.100.6.1619
Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957–2963. https://doi.org/10.1001/jama.270.24.2957
O'Neill WW, Grines C, Schreiber T, Moses J, Maini B, Dixon SR, et al. Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. Am Heart J 2018;202:33–38. https://doi.org/10.1016/j.ahj.2018.03.024
Barbaro RP, Odetola FO, Kidwell KM, Paden ML, Bartlett RH, Davis MM, et al. Association of hospital‐level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. Am J Respir Crit Care Med 2015;191:894–901. https://doi.org/10.1164/rccm.201409‐1634OC
Araki T, Kondo T, Imaizumi T, Sumita Y, Nakai M, Tanaka A, et al. Relationship between the volume of cases and in‐hospital mortality in patients with cardiogenic shock receiving short‐term mechanical circulatory support. Am Heart J 2023;261:109–123. https://doi.org/10.1016/j.ahj.2023.03.017